论文部分内容阅读
乙胺碘呋酮（Amisdarone，以下简称AI）于1974年由Rosenbaum等首先用于抗心律失常而显效，被许多作者公认为是一种疗效高、安全性大的广谱抗心律失常药物。晚近相继报道AI某些少见的毒副作用，甚至有致死亡者，应当引起临床医师警惕。
Amisdarone (AI) was first used by Rosenbaum et al in anti-arrhythmia in 1974 and has been recognized by many authors as a broad-spectrum antiarrhythmic drug with high efficacy and safety. Recently reported some rare AI side effects, and even those who died, should cause clinicians wary.